RenewVax raises €144K Seed round
6 August 2025· Liverpool, United Kingdom· health, biotech, ai, b2b, deep_hardware
The investment aims to accelerate the development of the company's first universal pneumococcal vaccine and combat antimicrobial resistance.
Investors
LeadLYVA Labs
About RenewVax
Stage
Seed
Headquarters
Liverpool, United Kingdom
Founded
2022
Team Size
6–20
Sectors
healthbiotechaib2bdeep_hardware
Source: https://lyvalabs.com/news/lyva-labs-reaches-2-5m-investment-milestone/